Skip to main content
OpenTrials
Completed

NCT Number: NCT01354990

A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)

The primary objective of this study is to obtain safety information on the use of sitagliptin (JANUVIA®) from endocrinologists, diabetologists, internists, and general practitioners.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Must be taking sitagliptin (JANUVIA™) for the treatment of type 2 diabetes

mellitus

  • Treating physician must agree to provide information regarding the participants treatment

Treatment and study plan

Sitagliptin (JANUVIA®)

Drug

Participants prescribed Sitagliptin (JANUVIA®) in routine clinical practice.

Primary outcomes

  1. Number of Participants With an Adverse Event

    Time frame: Up to approximately 28 months

  2. Age of Participants Prescribed Sitagliptin

    Time frame: Up to approximately 28 months

  3. Number of Participants With Concomitant Therapies

    Time frame: Up to approximately 28 months

  4. Number of Participants With Concomitant Conditions

    Time frame: Up to approximately 28 months

Sponsors and collaborators

Lead sponsor

Merck Sharp & Dohme LLC

Industry

Registry information

Official study title

Sitagliptin (JANUVIA®) Post Marketing Surveillance Protocol

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
May 17, 2011
Registry last updated
Aug 27, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.